Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice
Citation
S. Ikegami et al., Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice, NEUROSCI L, 279(3), 2000, pp. 129-132
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROSCIENCE LETTERS
SICI code
0304-3940(20000204)279:3<129:MWHAII>2.0.ZU;2-M
Abstract
Tau, one of the major neuronal microtubule-associated proteins (MAPs), is i
mportant for neuronal cell morphogenesis and axonal maintenance. Tau is als
o known to be a component of the paired helical filaments (PHFs) in Alzheim
er's disease patients. Recently, mutations in the tau gene were found in a
hereditary neurodegenarative disease called frontotemporal dementia and par
kinsonism linked to chromosome 17 (FTDP-17) which exhibits various neurolog
ical and neuropathological characteristics including PHF-like intracellular
tau deposit formation. Currently, the phenotype of the disease is thought
to be due to: (1) the toxicity of mutant tau molecules and and/or; (2) the
loss of function of normal tau molecules in patients' brains. To test the l
atter hypothesis, we performed behavioral and neurological tests on tau-def
icient mice. Tau-deficient mice showed muscle weakness in the wire-hanging
test, hyperactivity in a novel environment, and impairment in the contextua
l fear conditioning. They also had a tendency to fall more easily in the ro
d-walking test. These phenotypes parallel some signs and symptoms of FTDP-1
7 patients. Our results show that the loss of tau protein may itself lead t
o some of the neurological characteristics observed in FTDP-17 patients. (C
) 2000 Elsevier Science Ireland Ltd. All rights reserved.